These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37319387)

  • 1. Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer.
    Seagle HM; Keller SR; Tavtigian SV; Horton C; Holowatyj AN
    J Clin Oncol; 2023 Sep; 41(26):4279-4289. PubMed ID: 37319387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.
    Pearlman R; Frankel WL; Swanson B; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Liyanarachchi S; Kalady M; Heald B; Greenwood C; Paquette I; Prues M; Draper DJ; Lindeman C; Kuebler JP; Reynolds K; Brell JM; Shaper AA; Mahesh S; Buie N; Weeman K; Shine K; Haut M; Edwards J; Bastola S; Wickham K; Khanduja KS; Zacks R; Pritchard CC; Shirts BH; Jacobson A; Allen B; de la Chapelle A; Hampel H;
    JAMA Oncol; 2017 Apr; 3(4):464-471. PubMed ID: 27978560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Ethnic Disparities in Germline Genetic Testing of Patients With Young-Onset Colorectal Cancer.
    Dharwadkar P; Greenan G; Stoffel EM; Burstein E; Pirzadeh-Miller S; Lahiri S; Mauer C; Singal AG; Murphy CC
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):353-361.e3. PubMed ID: 33359728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals.
    Ukaegbu C; Levi Z; Fehlmann TD; Uno H; Chittenden A; Inra JA; Grover S; Kastrinos F; Syngal S; Yurgelun MB
    Fam Cancer; 2021 Apr; 20(2):111-116. PubMed ID: 32743790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline Genetic Features of Young Individuals With Colorectal Cancer.
    Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
    Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
    J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2-negative individuals who had genetic testing in a large urban comprehensive cancer center.
    Tatineni S; Tarockoff M; Abdallah N; Purrington KS; Assad H; Reagle R; Petrucelli N; Simon MS
    Cancer Med; 2022 Mar; 11(6):1465-1473. PubMed ID: 35040284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
    Fidder HH; Figer A; Geva R; Flex D; Schayek H; Avidan B; Meir SB; Friedman E
    Am J Gastroenterol; 2005 Jun; 100(6):1376-80. PubMed ID: 15929773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Inherited and Familial Component of Early-Onset Colorectal Cancer.
    Daca Alvarez M; Quintana I; Terradas M; Mur P; Balaguer F; Valle L
    Cells; 2021 Mar; 10(3):. PubMed ID: 33806975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer.
    Coughlin SE; Heald B; Clark DF; Nielsen SM; Hatchell KE; Esplin ED; Katona BW
    JCO Precis Oncol; 2022 Nov; 6():e2200517. PubMed ID: 36370464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Referral, Uptake, and Outcome of Genetic Counseling and Testing in Patients With Early-Onset Colorectal Cancer.
    Syed H; Sommovilla J; Burke CA; McGee S; Macaron C; Heald B; Lyu R; Schmit SL; Nair K; Kamath S; Krishnamurthi S; Khorana AA; Liska D
    J Natl Compr Canc Netw; 2023 Nov; 21(11):1156-1163.e5. PubMed ID: 37935108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of genetic testing in familial intermediate and late-onset colorectal cancer.
    Djursby M; Hansen TVO; Wadt KAW; Madsen MB; Berchtold LA; Lautrup CK; Markholt S; Jensen UB; Krogh LN; Lundsgaard M; Gerdes AM; Nilbert M; Therkildsen C
    Hum Genet; 2022 Dec; 141(12):1925-1933. PubMed ID: 35904628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis.
    Storandt MH; Rogen KR; Iyyangar A; Schnell RR; Mitchell JL; Hubbard JM; Sinicrope FA; Jatoi A; Mahipal A; Shi Q; Jin Z
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls.
    Akcay IM; Celik E; Agaoglu NB; Alkurt G; Kizilboga Akgun T; Yildiz J; Enc F; Kir G; Canbek S; Kilic A; Zemheri E; Ezberci F; Ozcelik M; Dinler Doganay G; Doganay L
    Int J Cancer; 2021 Jan; 148(2):285-295. PubMed ID: 32658311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for Lynch Syndrome.
    Hansen MF; Johansen J; Sylvander AE; Bjørnevoll I; Talseth-Palmer BA; Lavik LAS; Xavier A; Engebretsen LF; Scott RJ; Drabløs F; Sjursen W
    Clin Genet; 2017 Oct; 92(4):405-414. PubMed ID: 28195393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients.
    Jansen AM; Geilenkirchen MA; van Wezel T; Jagmohan-Changur SC; Ruano D; van der Klift HM; van den Akker BE; Laros JF; van Galen M; Wagner A; Letteboer TG; Gómez-García EB; Tops CM; Vasen HF; Devilee P; Hes FJ; Morreau H; Wijnen JT
    PLoS One; 2016; 11(6):e0157381. PubMed ID: 27300758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer.
    Heald B; Mokhtary S; Nielsen SM; Rojahn S; Yang S; Michalski ST; Esplin ED
    Gynecol Oncol; 2022 Aug; 166(2):344-350. PubMed ID: 35691755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
    Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
    Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rural-urban and racial/ethnic trends and disparities in early-onset and average-onset colorectal cancer.
    Zahnd WE; Gomez SL; Steck SE; Brown MJ; Ganai S; Zhang J; Arp Adams S; Berger FG; Eberth JM
    Cancer; 2021 Jan; 127(2):239-248. PubMed ID: 33112412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.